Waldenstroms Macroglobulinaemia
1 clinical trials · Condition
◉ Watch Waldenstroms Macroglobulinaemia
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) (NCT04728893) | Merck Sharp & Dohme LLC | 2021-04-05 |
Track Waldenstroms Macroglobulinaemia automatically
Every clearance here is in the API, with alerts when new ones post.